A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf.
Efficacy of vaccine Oncophage application in patients with renal cancer
2020
Onkourologiâ
Preserved Fulltext
Renal cancer is one of the most severe oncourologic diseases. In 2005, 15,733 new cases were registered in the Russian Federation. Total life expectancy of patients with advanced form of the disease is around one year unless patients respond to treatment with available late stage therapeutic agents. Therefore, delaying or preventing disease recurrence in patients with early-stage disease is critical. Oncophage was evaluated as an adjuvant treatment after nephrectomy in patients with high
doi:10.17650/1726-9776-2008-4-4-17-21
doaj:65b19a87c8b34d18ace8af0d3f38fa4a
fatcat:dgb3tk3myfcalj5nslgum5lrh4